i 123 MIBGmeta iodobenzylguanidine (AnazaoHealth Corporation)


Welcome to the PulseAid listing for the i 123 MIBG drug offered from AnazaoHealth Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: AnazaoHealth Corporation
NON-PROPRIETARY NAME: i 123 MIBG
SUBSTANCE NAME: IOBENGUANE SULFATE I-123
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00


i 123 MIBG meta iodobenzylguanidine HUMAN PRESCRIPTION DRUG Details:

Item Descriptioni 123 MIBG meta iodobenzylguanidine from AnazaoHealth Corporation
LABELER NAME: AnazaoHealth Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mCi/1)
START MARKETING DATE: 2012-05-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 51808-103_ea9f7125-98b5-49c3-85b8-763915156ff0
PRODUCT NDC: 51808-103
APPLICATION NUMBER:

Other IOBENGUANE SULFATE I-123 Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AnazaoHealth Corporationi 123 MIBG